成年人中的Vibrio cholerae的血清流行率,海地,2017年
Emerging infectious diseases
|August 23, 2023
概括
海地成年人的高霍乱抗体水平表明最近感染. 加强监测对于海地针对Vibrio cholerae O1的公共卫生干预至关重要.
科学领域:
- 流行病学 流行病学
- 传染性疾病 传染性疾病
- 公共卫生 公共卫生
背景情况:
- 霍乱在海地仍然是一个重要的公共卫生问题.
- 杀性抗体标位是最近感染Vibrio cholerae的关键指标.
- 了解感染患病率对于有效的控制策略至关重要.
研究的目的:
- 确定海地成年人血清中对Vibrio cholerae血清组O1的杀性抗体标位的流行率.
- 评估海地特定社区最近的霍乱感染负担.
主要方法:
- 2017年进行的横截面血清学调查.
- 在成年人群中测量血清对Vibrio cholerae血清组O1的杀性抗体标位.
- 从两个不同的位置收集数据:Cerca-la-Source和Mirebalais.
主要成果:
- 在Cerca-la-Source,杀性抗体的患病率为12.4%.
- 在Mirebalais,杀性抗体的患病率为9.54%.
- 这些发现表明,在研究的成年人群中,最近有相当大的Vibrio cholerae O1感染率.
结论:
- 观察到的抗体标位表明,海地最近的霍乱感染负担很高.
- 目前的监测计划可能需要改进,以有效监测霍乱的动态.
- 加强公共卫生监测对于指导干预和减轻海地未来的霍乱疫情至关重要.
关键词:
海地 海地 海地 海地 海地 海地 海地 海地霍乱病毒病毒 (Vibrio cholerae) 是一种病毒.抗体是对抗体的重要组成部分.霍乱是一种疾病,霍乱是霍乱.干燥的血液斑点 干燥的血液斑点血清流行病学疫苗可以预防的疾病.病毒病毒病毒病毒.更多相关视频
相关概念视频
Prevalence and Incidence
627
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
627
Healthcare Associated Infections II: Preventive Measures
2.7K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
2.7K
Sexually Transmitted Infections
348
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
348
Principles of Disease Surveillance
124
Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
124
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
4.3K
Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
4.3K
Hazard Ratio
157
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
157


